With two molecules in mid-stage trials, the pharma giant is taking another swing at the difficult disease with a greater ...

DelveInsight's Triple-Negative Breast Cancer Market Insights report includes a comprehensive understanding of current ...

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...

Shares in the $247 bln obesity drugmaker fell over 20% after it said sales would grow more slowly than expected. Competition ...

Trump appears desperate to change the subject from that of his former pal and convicted sex offender, Jeffrey Epstein, and it ...